US3926723A - Method of controllably releasing glucose to a cell culture medium - Google Patents
Method of controllably releasing glucose to a cell culture medium Download PDFInfo
- Publication number
- US3926723A US3926723A US495609A US49560974A US3926723A US 3926723 A US3926723 A US 3926723A US 495609 A US495609 A US 495609A US 49560974 A US49560974 A US 49560974A US 3926723 A US3926723 A US 3926723A
- Authority
- US
- United States
- Prior art keywords
- glucose
- improvement
- serum
- culture medium
- glucosidase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 142
- 239000008103 glucose Substances 0.000 title claims abstract description 142
- 239000006143 cell culture medium Substances 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 title claims description 13
- 239000001963 growth medium Substances 0.000 claims abstract description 47
- 239000002609 medium Substances 0.000 claims abstract description 39
- 102000004190 Enzymes Human genes 0.000 claims abstract description 36
- 108090000790 Enzymes Proteins 0.000 claims abstract description 36
- 230000000694 effects Effects 0.000 claims abstract description 36
- 229920002472 Starch Polymers 0.000 claims abstract description 35
- 239000008107 starch Substances 0.000 claims abstract description 35
- 235000019698 starch Nutrition 0.000 claims abstract description 35
- 102000004366 Glucosidases Human genes 0.000 claims abstract description 31
- 108010056771 Glucosidases Proteins 0.000 claims abstract description 31
- 102000016679 alpha-Glucosidases Human genes 0.000 claims abstract description 28
- 108010028144 alpha-Glucosidases Proteins 0.000 claims abstract description 28
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims abstract description 25
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 25
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims abstract description 22
- 239000012894 fetal calf serum Substances 0.000 claims abstract description 22
- 102000013142 Amylases Human genes 0.000 claims abstract description 19
- 108010065511 Amylases Proteins 0.000 claims abstract description 19
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 17
- 239000004382 Amylase Substances 0.000 claims abstract description 16
- 235000019418 amylase Nutrition 0.000 claims abstract description 15
- 150000004676 glycans Chemical class 0.000 claims abstract description 14
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 14
- 239000005017 polysaccharide Substances 0.000 claims abstract description 14
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 12
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 12
- 230000001105 regulatory effect Effects 0.000 claims abstract description 4
- 210000002966 serum Anatomy 0.000 claims description 50
- 230000006872 improvement Effects 0.000 claims description 44
- 210000004962 mammalian cell Anatomy 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 13
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 12
- 238000004113 cell culture Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 229920002527 Glycogen Polymers 0.000 claims description 6
- 229940096919 glycogen Drugs 0.000 claims description 6
- 238000013268 sustained release Methods 0.000 claims description 5
- 239000012730 sustained-release form Substances 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims description 2
- 239000012090 serum-supplement Substances 0.000 abstract description 8
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 abstract description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 6
- 238000013270 controlled release Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 43
- 229940088598 enzyme Drugs 0.000 description 24
- 230000012010 growth Effects 0.000 description 12
- 241000272184 Falconiformes Species 0.000 description 8
- 238000007792 addition Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 244000309466 calf Species 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 229910052740 iodine Inorganic materials 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000004366 Glucose oxidase Substances 0.000 description 3
- 108010015776 Glucose oxidase Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 229940116332 glucose oxidase Drugs 0.000 description 3
- 235000019420 glucose oxidase Nutrition 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000037351 starvation Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000001720 carbohydrates Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 125000003071 maltose group Chemical group 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000006395 oxidase reaction Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
Definitions
- a cell culture medium which contains secondary sources of glucose comprising glucosecontaining oligosaccharides or polysaccharides and hydrolytic enzymes (glucosidases) to liberate free glucose.
- Starch for example, can be added to a culture medium to provide the controlled release of glucose when a serum supplement such as fetal calf serum, which contains the hydrolytic enzymes amylase and maltase, is used.
- Amylase breaks the starch down into glucose and maltose, and maltase converts the remaining maltose to glucose.
- the rate of glucose release can be controlled by regulating the amount of glucosidase activity present in the medium.
- Mammalian cells are typically grown in a culture medium to which a serum supplement is added.
- culture media including Eagles medium, the Dulbecco-Vogt modification of Eagles medium, and Hams medium. In general, these are synthetic formulations designed to. provide sources of amino acids, vitamins, glucose, etc. to the growing cells.
- the serumv supplement is added to provide certain proteins to the culture, and typical serum supplements include calf serum, fetal calf serum, and horse serum.
- glucose is still the sugar mostly widely used in mammalian cell cultures, although it has been noted that cell growth could take place on maltose or glycogen after their hydrolysis by enzymes of embryo extract or serum. See Harris, M. and Kutsky, P. B., J. Cell Comp. PhysioL, 42, 449 (1953).
- glucose in culture media does cause some problems, however. The most serious of these is that the glucose is consumed rapidly. Since cells cannot survive when their glucose supply has been exhausted, frequent refeeding to replenish the supply is necessary.- Further, high concentrations of glucose are not used efficiently by growing cells because the cells ferment more glucose than they can oxidize. This results in an accumulation of lactic acid, a fermentation product, in the medium which produces a concomitant drop in pH which is deleterious to cell growth. See Ceccarini, C. and Eagle, I-I., Proc. Nat. Acad. Sci. USA, 68, 229 (1971).
- the invention comprises the use of secondary sources of glucose in cell culture media,
- Suitable secondary sources of glucose include either a glucose-containing oligosaccharide or polysaccharide and a glucosidase, or enzyme capable of releasing glucose from the glucose-containing compounds.
- Suitable glucosidase activity can be provided by choosing serum supplement containing the desired hydrolytic enzyme or'enzymes. Alternatively, commercial preparations of a glucosidase can be added to the culture medium.
- the rate of glucose release to the culture medium can be controlled by adjusting the glucosidase activity present.
- the rate can be reduced by partially inactivating the glucosidase activity in the serum supplement by heating the serum to an elevated temperature prior to its addition to the culture medium.
- hydrolytic enzymes can be added to culture media to adjust the glucosidase activity to the desired level for any specific oligosaccharide or polysaccharide.
- glucose is starch together-with the hydrolytic enzymes amylase and maltase.
- the amylase breaks starch down to predominantly maltose units and the maltase completes the hydrolysis to glucosel
- Another secondary source is the sugar maltose which is hydrolyzed by the enzyme maltase.
- glucose is released by both systems.
- a primary advantage is that any desired rate of glucose release to the cell culture medium can be achieved for extended periods of time. Low concentrations of glucose cannot be maintained by direct addition because the growing cells consume the glucose so rapidly. In the new system, glucose continues to be available to the cells at a time when it would have been exhausted if supplied to the medium directly.
- FIG. 1 illustrates graphically the growth rate of established mammalian cell lines at various glucose concentrations.
- FIG. 2 illustrates graphically the efficiency of cell utilization of glucose at different concentrations
- FIG. 3 illustrates graphically the release of glucose from the secondary source starch using fetal calf serum which contains amylase and maltase;
- FIG. 4 illustrates graphically the inactivation of serum enzymes with heat
- FIG. 5 illustrates graphically certain conditions resulting from the growth of V79 cells in various culture media containing glucose, starch, plus amylase or maltose plus maltase;
- FIG. 6 illustrates graphically the growth of V79 cells on maltose in a culture medium containing serum with maltase inactivated by heat.
- Secondary glucose sources can be added to a wide variety of cell culture media.
- Some of the better known and widely used media include Eagles medium, the Dulbecco-Vogt modification of Eagless medium, and Hams medium. It should be clear, however, that other media known to those skilled in the art can be provided with secondary glucose sources as described herein.
- Suitable secondary sources of glucose can be a glucose-containing oligosaccharide or polysaccharide together with appropriate glucosidase activity.
- the release of glucose can be illustrated for the oligosaccharide maltose used in combination with the enzyme maltase as follows:
- Glucose Amylase hydrolyzes starch to glucose and maltose, and the maltose is hydrolyzed into glucose by the enzyme maltase. Itis preferable, therefore, to include both amylase and maltase in a culture medium if starch is the secondary source of glucose.
- All glucose-containing oligosaccharides or polysaccharides which, can be broken down to release glucose by an appropriate glucosidase are suitable secondary sources.
- oligosaccharides containing glucose include, but are not limited to, maltose, sucrose, lactose, and raffinose.
- glucosecontaining polysaccharides include, but are not limited to glycogen and starch.
- Other compounds containing glucosyl moiety which can be released may also be useful. These include, for example, synthetically prepared glucosides.
- FIG. 1 illustrates how the doubling time of a number of established mammalian cell lines in the Dulbecco-Vogt modification of Eagles medium CH OH Glucose supplemented with l0% dialyzed calf serum or fetal calf serum depends on the glucose concentration of the medium. These determinations were carried out by inoculating 32 mm petri dishes with or 10 cells in 2.0 ml of medium and counting the number of cells per culture at daily intervals.
- the doubling times taken from the exponential portion of the growth curves are independent of glucose concentration at the physiological range (1 mg/ml) or higher. Below 300 ,ug/ml the growth rates decline; but even at 1 pg/ml, a glucose concentration 1,000 fold lower than physiological, two of the lines grow with a doubling time of less than 50 hours without any initial delay attributable to adaptation. At still lower glucose concentrations, cell number does not increase and there is noticeable cell death and detachment. From these experiments, it can be seen that the preferred glucose concentration in a mammalian cell medium is from about one microgram to about 100 micrograms per milliliter of medium. Mass cultures can be grown indefinitely generations) at these glucose concentrations if the cell number is kept low and the cultures transferred before the glucose is consumed.
- FIG. 2 shows the number of cells grown per unit of glucose consumed at varying glucose concentrations. Cultures with different initial glucose concentrations were formed by inoculating petri dishes containing 2.0 ml of Dulbecco-Vogt modification of Eagles medium and 10% dialyzed calf serum with 10" cells which were allowed to grow to maximal cell density. This density was attained when all the glucose was consumed. These cultures were not refed. Ordinate values were derived from the ratio,
- the number of cells produced is 5-20 fold greater than at the physiological concentration of about 1 mg/ml.
- the maximum cell number in fetal calf serum is 20-40% higher than in calf serum.
- FIGS. 1 and 2 Doubling times and maximal cell density in low glucose concentrations were estimated for FIGS. 1 and 2 as follows. Subconfluent, growing cultures in medium containing 4.5 mg/ml glucose and 10% calf serum were removed with isotonic EDTA and trypsin, diluted into glucose-free medium for counting, then centrifuged and resuspended in fresh glucose-free medium. 10 or 10 cells were plated in duplicate 32 mm dishes containing 2.1 ml of medium with 10% dialyzed calf serum and different glucose concentrations. Beginning two to four days later, cultures were trypsinized and the cells were counted daily until the cultures failed to increase in cell number and began to degenerate due to glucose starvation.
- One method of conveniently adding the appropriate glucosidase to a culture medium is to select a serum supplement which contains the desired hydrolytic enzyme activity.
- different types of serum contain differing types and amounts of enzyme activity.
- calf serum has been found to have threefold greater activity of a-amylase than fetal calf serum, whereas horse serum has less than 10% of the activity of fetal calf serum. Because of these differences, a convenient method of controlling the amount of any particular glucosidase activity in the culture is to select a serum containing the particular enzyme activity desired and to add the serum in an amount sufficient to provide the desired level of activity.
- a serum having too high an activity for example, can be heated to an elevated temperature and cooled prior to its addition to the culture medium to provide the desired activity level.
- EXAMPLE 1 Digestion of Starch and Liberation of Glucose by Enzymes of Fetal Calf Serum under Cell Culture Conditions A 10% stock solution of starch was prepared by dissolving 5 grams of soluble starch, B grade (Calbiochem) in 50 nil of glass distilled water by heating for about 30 minutes in a boiling water bath, and then autoclaving for 15 minutes at 25 psi.
- Glucose and starch determinations were done as follows.
- the glucose oxidase reaction coupled with the oxidation of a chromogen (Glucostat special, Worthington Biochemical Corp.) gives a -yellow-brown color with maximum absorption at 400 nm.
- a chromogen Glucostat special, Worthington Biochemical Corp.
- 0.6 ml of diluted unknowns, standards and a glucose-free blank were deproteinized by the successive additions of 0.3 ml of 2% ZnSO .7H O and 0.3 ml 0.46% NaOH and centrifuged at 4,000 g for 10 min.
- Equal volumes of the supernatant and glucostat reagent were mixed and incubated at 37C.; the reaction was stopped by the addition of two drops of 4.0 N HCl.
- the length of incubation with the glucostat reagent was adjusted to make the absorption of the standard solutions proportional to their glucose concentration in the range of interest.
- Iodine reagent was prepared by adding 18 mg iodine dissolved in 1 ml ethanol, to 320 ml of 3.5 mM K]. Concentrated HCl was added to a concentration of 0.01 N. The reagent was stored in a brown bottle and was prepared fresh every other day. Starch solutions were diluted from 1:1 to 1:40 in iodine reagent so as to give absorption proportional to starch concentration over a range of 20 pg-S mg perml. The
- This serum supported growth as well as undialyzed serum, but glucose-free Dulbecco-Vogt medium could not substitute for Hams medium in the final dialysis without reduction in growth rate and cloning efficiency.
- the level of glucose in the dialyzed serum was below the limit of detection by the glucose oxidase assay l ug/ml).
- the serum was sterilized by filtration before use.
- FIG. 4 shows that the ability to release glucose from starch was virtually completely lost after heating at 65C. for 90 min. The maltase activity was more resistant; its inactivation required 30 min. at 70C. In the absence of serum, the glucose oxidase assay of'a 5 mg/ml maltose solution gave a value of 4 ug/ml of glucose equivalent; this may represent contaminating glucose. 9
- V79 cells 5x10 were inoculated into 32 mm petri dishes containing 2.0 ml of glucose-free Dulbecco- Vogt modification of Eagles medium. 4.5 mg/ml of either starch, maltose or glucose were added.
- V79 cells grew on glucose liberated from starch or maltose by the enzymes of fetal calf serum with virtually no initial period of glucose starvation as shown in the upper panel of FIG. 5.
- the growth curves of V79 cells in starch, maltose or glucose were virtually identical, the doubling time being about 12 hours.
- the middle panel of FIG. 5 shows that cells grown in free glucose consumed nearly 90% of the added glucose in ten days. Glucose liberated from maltose or starch by the serum was not appreciably consumed by the cells for the first three days, but thereafter the increased cell number reduced the glucose concentration to very low levels, production and consumption presumably continuing concurrently.
- the bottom panel of FIG. 5 shows how the pH of the medium was affected by the source of glucose in the culture.
- the pH eventually dropped below 6.6.
- the pH fell very little; the final values were 7.0 for maltose and 7.1 for starch, scarcely lower than the starting-value. From this data, it is clear that at the lower glucose levels maintained by sustained release from starch or maltose, more efficient glucose utilization results in much less acid production.
- EXAMPLE 5 Growth of V79 Cells on Reduced Initial Concentrations of Glucose and Maltose
- the procedure of Example 4 was followed except that an initial concentration of glucose of 500 ug/ml was used, and a low initial concentration of maltase activity was established by using a fetal calf serum supplement consisting of 9 parts heat inactivated serum 30 minutes) and one part unheated serum.
- the growth rate in added glucose was a little more rapid than in maltose as shown in the upper panel of FIG. 6.
- the glucose was no longer detectable in the medium; cell number did not increase further, and two days later began to decline, due to cell death and detachment.
- the maltose-grown cells reached a higher saturation density and remained healthy in appearance; free glucose could be detected in the medium throughout the experiment as shown in the bottom panel of FIG. 6.
- V79 cells Growth of V79 Cells on Glucose Released From Glycogen by Amylase in Fetal Calf Serum V79 cells (10 were inoculated into culture media prepared as in Example 3 but substituting glycogen for starch. Each day the cultures were examined by microscope and it was observed that the cells grew at the same rate and to the same density as a culture containing glucose, but the medium did not become acidic.
- hydrolytic enzyme comprises a glucosidase
- polysaccharide comprises starch and said glucosidase comprises amylase and maltase.
- polysaccharide comprises glycogen and said glucosidase comprises amylase and maltase.
- said serum comprises fetal calf serum.
- said serum comprises fetal calf serum.
- amylase and maltase are supplied to said culture medium by adding fetal calf serum thereto.
- glucosidase is included in an amount sufficient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
- glucosidase is included in an amount suflicient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
- hydrolytic enzyme comprises a glucosidase
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
A cell culture medium is disclosed which contains secondary sources of glucose comprising glucose-containing oligosaccharides or polysaccharides and hydrolytic enzymes (glucosidases) to liberate free glucose. Starch, for example, can be added to a culture medium to provide the controlled release of glucose when a serum supplement such as fetal calf serum, which contains the hydrolytic enzymes amylase and maltase, is used. Amylase breaks the starch down into glucose and maltose, and maltase converts the remaining maltose to glucose. The rate of glucose release can be controlled by regulating the amount of glucosidase activity present in the medium.
Description
United States Patent [191 Green et al.
[ 1 Dec. 16, 1975 METHOD OF CONTROLLABLY RELEASING GLUCOSE TO A CELL CULTURE MEDIUM [75] Inventors: Howard Green, Brookline; James G.
Rheinwald, Cambridge, both of Mass.
[73] Assignee: Massachusetts Institute of Technology, Cambridge, Mass.
[22] Filed: Aug. 8, 1974 [21] Appl. No.: 495,609
OTHER PUBLICATIONS Chem. Abstracts 76:1 37424(e). Chem. Abstracts 48:4080h.
Parker, Methods of Tissue Culture, 3 ed., Harper & Row, 1961, pp. 215-217.
Primary ExaminerA. Louis Monacell Assistant ExaminerThomas G. Wiseman Attorney, Agent, or FirmArthur A. Smith, Jr.; Martin M. Santa; David E. Brook ABSTRACT A cell culture medium is disclosed which contains secondary sources of glucose comprising glucosecontaining oligosaccharides or polysaccharides and hydrolytic enzymes (glucosidases) to liberate free glucose. Starch, for example, can be added to a culture medium to provide the controlled release of glucose when a serum supplement such as fetal calf serum, which contains the hydrolytic enzymes amylase and maltase, is used. Amylase breaks the starch down into glucose and maltose, and maltase converts the remaining maltose to glucose. The rate of glucose release can be controlled by regulating the amount of glucosidase activity present in the medium.
23 Claims, 6 Drawing Figures DOUBLTNG TIME (hours) GLUCOSE CONCENTRATION NUMBER OF CELLS PRODUCED PER NANOGRAM 0F GLUCOSE CONSUMED I I l GLUCOSE CONCENTRATION (,u-g/ml') FIG. 2.
METHOD OF CONTROLLABLY RELEASING GLUCOSE TO A CELL CULTURE MEDIUM The invention herein described was made in the course of work performed with a grant from the Department of Health, Education and Welfare.
BACKGROUND OF THE INVENTION 1. Field of the Invention I The invention is in the field of biology, and more specifically in the field .of cell biology. v
2. Description of the Prior Art Mammalian cells are typically grown in a culture medium to which a serum supplement is added. There are several well known culture media including Eagles medium, the Dulbecco-Vogt modification of Eagles medium, and Hams medium. In general, these are synthetic formulations designed to. provide sources of amino acids, vitamins, glucose, etc. to the growing cells. The serumv supplement is added to provide certain proteins to the culture, and typical serum supplements include calf serum, fetal calf serum, and horse serum. i I
It has heretofore been common to provide relatively high concentrations of glucose, e.g., greater than about 1 mg/ml, in culture media to provide a source of carbon and energy to the growing cells. Utilization by mammalian cell cultures of sugars other than glucose has, however, been studied extensively. See, for example, Harris, M. and Kutsky, P. B., J. Cell Comp. PhysioL, 42,
449 (1953); Eagle, H., Barban, S., Levy, M., and- Schulz, H. 0., J. Biol, Chem., 233, 551 (1958); Bailey, J. M., Gey, G. 0., and Gey, M. K., J. Biol. Chem, 234, 1042 (1959); Baugh, C. L. and Tytell, A. A., Life Sciences, 6, 371 (1967); Martineau, R. Kohlbacher, M., Shaw, S. N., and Amos, H.', Proc. Nat. Acad, Sci. USA, 69, 3407 (1972); Kalckar', H. M. and Ullrey, D., Proc. Nat. Acad. Sci. USA, 70, 2502 (1973); and Paul, .I., In Cells and Tissues in Culture, Vol. 1, Willmer,E. N., ed., Academic Press, New York, 239 (1965). From such studies, it has been determined that mannose and fructose are metabolised rapidly, but galactose is utilized more slowly and produces less lactate. See Eagle, H. Barban, S., Levy, M. and Schulze, H. 0., J. Biol. Chem., 233, 551 (1958). In spite of these extensive studies,
glucose is still the sugar mostly widely used in mammalian cell cultures, although it has been noted that cell growth could take place on maltose or glycogen after their hydrolysis by enzymes of embryo extract or serum. See Harris, M. and Kutsky, P. B., J. Cell Comp. PhysioL, 42, 449 (1953).
The use of glucose in culture media does cause some problems, however. The most serious of these is that the glucose is consumed rapidly. Since cells cannot survive when their glucose supply has been exhausted, frequent refeeding to replenish the supply is necessary.- Further, high concentrations of glucose are not used efficiently by growing cells because the cells ferment more glucose than they can oxidize. This results in an accumulation of lactic acid, a fermentation product, in the medium which produces a concomitant drop in pH which is deleterious to cell growth. See Ceccarini, C. and Eagle, I-I., Proc. Nat. Acad. Sci. USA, 68, 229 (1971).
SUMMARY OF THE INVENTION In one embodiment, the invention comprises the use of secondary sources of glucose in cell culture media,
particularly those intended for mammalian cells. Suitable secondary sources of glucose include either a glucose-containing oligosaccharide or polysaccharide and a glucosidase, or enzyme capable of releasing glucose from the glucose-containing compounds. Suitable glucosidase activity can be provided by choosing serum supplement containing the desired hydrolytic enzyme or'enzymes. Alternatively, commercial preparations of a glucosidase can be added to the culture medium.
' The rate of glucose release to the culture medium can be controlled by adjusting the glucosidase activity present. For example, the rate can be reduced by partially inactivating the glucosidase activity in the serum supplement by heating the serum to an elevated temperature prior to its addition to the culture medium.
Alternatively, different amounts or types of hydrolytic enzymes, or serum supplements containing hydrolytic enzymes, can be added to culture media to adjust the glucosidase activity to the desired level for any specific oligosaccharide or polysaccharide.
One suitable secondary source of glucose is starch together-with the hydrolytic enzymes amylase and maltase. The amylase breaks starch down to predominantly maltose units and the maltase completes the hydrolysis to glucosel Another secondary source is the sugar maltose which is hydrolyzed by the enzyme maltase. Thus, glucose is released by both systems.
Providing glucose to culture media from secondary sources ofiers significant advantages over the direct addition of glucose. A primary advantage is that any desired rate of glucose release to the cell culture medium can be achieved for extended periods of time. Low concentrations of glucose cannot be maintained by direct addition because the growing cells consume the glucose so rapidly. In the new system, glucose continues to be available to the cells at a time when it would have been exhausted if supplied to the medium directly.
Supplying constant but relatively low levels of glucose to the cell culture from secondary sources also helps to maintain the pH of the culture medium within a beneficial range. This is primarily because little or no lactic acid is formed, since the growing cells metabolize completely the glucose liberated from the secondary source. Thus, the cells can be grown to a higher density and maintained healthier for longer periods of time than in media to which glucose is added directly, and frequent refeeding of cultures to supply glucose is eliminated.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 illustrates graphically the growth rate of established mammalian cell lines at various glucose concentrations.
FIG. 2 illustrates graphically the efficiency of cell utilization of glucose at different concentrations;
FIG. 3 illustrates graphically the release of glucose from the secondary source starch using fetal calf serum which contains amylase and maltase;
FIG. 4 illustrates graphically the inactivation of serum enzymes with heat;
FIG. 5 illustrates graphically certain conditions resulting from the growth of V79 cells in various culture media containing glucose, starch, plus amylase or maltose plus maltase;
FIG. 6 illustrates graphically the growth of V79 cells on maltose in a culture medium containing serum with maltase inactivated by heat.
DESCRIPTION OF THE PREFERRED EMBODIMENTS The provision of secondary glucose sources in culture media is useful in most cell cultures and is particu-. larly useful in mammalian cell cultures. Suchmammalian cells as 3T3 and 3T6 (mouse embryonic fibroblast lines), SVPy3T3-l 1, a 3T3 line doubly transformed by polyoma and SV40, human diploid fibroblasts, V79, (a line derived from Chinese hamster embryonic lung fibroblasts), and HeLa (human carcinona); as well as other mammalian cell lines can be grown in media containing secondary glucose sources.
Secondary glucose sources can be added to a wide variety of cell culture media. Some of the better known and widely used media include Eagles medium, the Dulbecco-Vogt modification of Eagless medium, and Hams medium. It should be clear, however, that other media known to those skilled in the art can be provided with secondary glucose sources as described herein.
Suitable secondary sources of glucose can be a glucose-containing oligosaccharide or polysaccharide together with appropriate glucosidase activity. The release of glucose can be illustrated for the oligosaccharide maltose used in combination with the enzyme maltase as follows:
Maltese Similarly, the release of glucose from the polysaccharide starch by the enzymes amylase and maltase can be illustrated as follows:
Glucose maltase; 2
Glucose Amylase hydrolyzes starch to glucose and maltose, and the maltose is hydrolyzed into glucose by the enzyme maltase. Itis preferable, therefore, to include both amylase and maltase in a culture medium if starch is the secondary source of glucose.
All glucose-containing oligosaccharides or polysaccharides which, can be broken down to release glucose by an appropriate glucosidase are suitable secondary sources. Examples of oligosaccharides containing glucose include, but are not limited to, maltose, sucrose, lactose, and raffinose. Suitable examples of glucosecontaining polysaccharides include, but are not limited to glycogen and starch. Other compounds containing glucosyl moiety which can be released may also be useful. These include, for example, synthetically prepared glucosides.
Secondary sources of glucose are particularly useful in cultures where it is desired to maintain a relatively constant but low concentration of glucose. Whereas most previous systems used glucose at the physiological range (1 mg/ml) or higher, it has been demonstrated that much lower concentrations can be used to achieve beneficial results. FIG. 1 illustrates how the doubling time of a number of established mammalian cell lines in the Dulbecco-Vogt modification of Eagles medium CH OH Glucose supplemented with l0% dialyzed calf serum or fetal calf serum depends on the glucose concentration of the medium. These determinations were carried out by inoculating 32 mm petri dishes with or 10 cells in 2.0 ml of medium and counting the number of cells per culture at daily intervals. The doubling times taken from the exponential portion of the growth curves are independent of glucose concentration at the physiological range (1 mg/ml) or higher. Below 300 ,ug/ml the growth rates decline; but even at 1 pg/ml, a glucose concentration 1,000 fold lower than physiological, two of the lines grow with a doubling time of less than 50 hours without any initial delay attributable to adaptation. At still lower glucose concentrations, cell number does not increase and there is noticeable cell death and detachment. From these experiments, it can be seen that the preferred glucose concentration in a mammalian cell medium is from about one microgram to about 100 micrograms per milliliter of medium. Mass cultures can be grown indefinitely generations) at these glucose concentrations if the cell number is kept low and the cultures transferred before the glucose is consumed.
The efficiency of glucose utilization is also improved by using lower glucose concentrations. This is illustrated in FIG. 2 which shows the number of cells grown per unit of glucose consumed at varying glucose concentrations. Cultures with different initial glucose concentrations were formed by inoculating petri dishes containing 2.0 ml of Dulbecco-Vogt modification of Eagles medium and 10% dialyzed calf serum with 10" cells which were allowed to grow to maximal cell density. This density was attained when all the glucose was consumed. These cultures were not refed. Ordinate values were derived from the ratio,
At l-3 mg/ml, the number of cells produced is 5-20 fold greater than at the physiological concentration of about 1 mg/ml. At all glucose concentrations, the maximum cell number in fetal calf serum is 20-40% higher than in calf serum.
Doubling times and maximal cell density in low glucose concentrations were estimated for FIGS. 1 and 2 as follows. Subconfluent, growing cultures in medium containing 4.5 mg/ml glucose and 10% calf serum were removed with isotonic EDTA and trypsin, diluted into glucose-free medium for counting, then centrifuged and resuspended in fresh glucose-free medium. 10 or 10 cells were plated in duplicate 32 mm dishes containing 2.1 ml of medium with 10% dialyzed calf serum and different glucose concentrations. Beginning two to four days later, cultures were trypsinized and the cells were counted daily until the cultures failed to increase in cell number and began to degenerate due to glucose starvation.
One method of conveniently adding the appropriate glucosidase to a culture medium is to select a serum supplement which contains the desired hydrolytic enzyme activity. As is known, different types of serum contain differing types and amounts of enzyme activity. For example, calf serum has been found to have threefold greater activity of a-amylase than fetal calf serum, whereas horse serum has less than 10% of the activity of fetal calf serum. Because of these differences, a convenient method of controlling the amount of any particular glucosidase activity in the culture is to select a serum containing the particular enzyme activity desired and to add the serum in an amount sufficient to provide the desired level of activity. Alternatively, another convenient method for reducing the rate of hydrolysis is to use heat to inactivate part of the enzymatic-activity. A serum having too high an activity, for example, can be heated to an elevated temperature and cooled prior to its addition to the culture medium to provide the desired activity level.
The invention is further illustrated by the following examples:
EXAMPLE 1 Digestion of Starch and Liberation of Glucose by Enzymes of Fetal Calf Serum under Cell Culture Conditions A 10% stock solution of starch was prepared by dissolving 5 grams of soluble starch, B grade (Calbiochem) in 50 nil of glass distilled water by heating for about 30 minutes in a boiling water bath, and then autoclaving for 15 minutes at 25 psi.
One part of the stock starch solution was introduced into 20 parts of serum-free, Dulbecco-Vogt modification of Eagle s medium. The medium was maintained at 37C. for over 20 days, after which time there was no detectable decline in the amount of starch and no liberation of glucose.
The same procedure was followed except substituting medium containing 10% fetal calf serum. This time, starch disappeared with a half-life of about 35 minutes and was near the limit of detection 4 hours later. Glucose appeared in the medium, but less rapidly, since molecules containing fewer than 8 saccharide units give no color in the starch-iodine reaction, but must be further hydrolyzed to yield glucose. The glucose concentration in the medium reached 25 ag/ml within an hour, a concentration fully able to support cell growth. The concentration rose to pig/ml by four hours, and continued to rise until, by about 10 days, a maximum of about 50% of the starch was converted to glucose.
Glucose and starch determinations were done as follows. The glucose oxidase reaction, coupled with the oxidation of a chromogen (Glucostat special, Worthington Biochemical Corp.) gives a -yellow-brown color with maximum absorption at 400 nm. 0.6 ml of diluted unknowns, standards and a glucose-free blank were deproteinized by the successive additions of 0.3 ml of 2% ZnSO .7H O and 0.3 ml 0.46% NaOH and centrifuged at 4,000 g for 10 min. Equal volumes of the supernatant and glucostat reagent were mixed and incubated at 37C.; the reaction was stopped by the addition of two drops of 4.0 N HCl. The length of incubation with the glucostat reagent was adjusted to make the absorption of the standard solutions proportional to their glucose concentration in the range of interest. The assay was accurate over a range of 1 pg/ml to 5 mg/ml.
A modification of the iodine method of Smith and Roe (1949) was used. Iodine reagent was prepared by adding 18 mg iodine dissolved in 1 ml ethanol, to 320 ml of 3.5 mM K]. Concentrated HCl was added to a concentration of 0.01 N. The reagent was stored in a brown bottle and was prepared fresh every other day. Starch solutions were diluted from 1:1 to 1:40 in iodine reagent so as to give absorption proportional to starch concentration over a range of 20 pg-S mg perml. The
color is stable for several hours at dilutions of 1:20 or 1:40 of sample to reagent, but fades rapidly at 1:1 dilution.
The results of this Example are shown graphically in FIG. 3.
EXAMPLE 2 Inactivation of Serum Enzymes Liberating Glucose from Starch and from Maltose Glucose-free, fetal calf serum, which contains amylase and maltase, was heated in a water bath under various conditions and then tested for its ability to release glucose from starch. The serum was dialyzed at 4C. for 24 hours against three changes of 20 volumes of isotonic phosphate buffered salt solution (pH 7.3) and finally for -18 hrs. against 5 volumes of glucosefree F12 medium (Ham, 1965). This serum supported growth as well as undialyzed serum, but glucose-free Dulbecco-Vogt medium could not substitute for Hams medium in the final dialysis without reduction in growth rate and cloning efficiency. The level of glucose in the dialyzed serum was below the limit of detection by the glucose oxidase assay l ug/ml). The serum was sterilized by filtration before use.
FIG. 4 shows that the ability to release glucose from starch was virtually completely lost after heating at 65C. for 90 min. The maltase activity was more resistant; its inactivation required 30 min. at 70C. In the absence of serum, the glucose oxidase assay of'a 5 mg/ml maltose solution gave a value of 4 ug/ml of glucose equivalent; this may represent contaminating glucose. 9
EXAMPLE 3 Growth of V79 Cells on Starch or Maltose as Secondary Glucose Sources V79 cells (5x10 were inoculated into 32 mm petri dishes containing 2.0 ml of glucose-free Dulbecco- Vogt modification of Eagles medium. 4.5 mg/ml of either starch, maltose or glucose were added.
The V79 cells grew on glucose liberated from starch or maltose by the enzymes of fetal calf serum with virtually no initial period of glucose starvation as shown in the upper panel of FIG. 5. The growth curves of V79 cells in starch, maltose or glucose were virtually identical, the doubling time being about 12 hours.
The middle panel of FIG. 5 shows that cells grown in free glucose consumed nearly 90% of the added glucose in ten days. Glucose liberated from maltose or starch by the serum was not appreciably consumed by the cells for the first three days, but thereafter the increased cell number reduced the glucose concentration to very low levels, production and consumption presumably continuing concurrently.
The bottom panel of FIG. 5 shows how the pH of the medium was affected by the source of glucose in the culture. When the high concentration of free glucose was present from the outset, the pH eventually dropped below 6.6. In cultures containing secondary glucose sources, the pH fell very little; the final values were 7.0 for maltose and 7.1 for starch, scarcely lower than the starting-value. From this data, it is clear that at the lower glucose levels maintained by sustained release from starch or maltose, more efficient glucose utilization results in much less acid production.
EXAMPLE 5 Growth of V79 Cells on Reduced Initial Concentrations of Glucose and Maltose The procedure of Example 4 was followed except that an initial concentration of glucose of 500 ug/ml was used, and a low initial concentration of maltase activity was established by using a fetal calf serum supplement consisting of 9 parts heat inactivated serum 30 minutes) and one part unheated serum. Under these conditions, the growth rate in added glucose was a little more rapid than in maltose as shown in the upper panel of FIG. 6. By the fourth day, however, the glucose was no longer detectable in the medium; cell number did not increase further, and two days later began to decline, due to cell death and detachment. The maltose-grown cells reached a higher saturation density and remained healthy in appearance; free glucose could be detected in the medium throughout the experiment as shown in the bottom panel of FIG. 6.
EXAMPLE 6 Growth of V79 Cells on Glucose Released From Glycogen by Amylase in Fetal Calf Serum V79 cells (10 were inoculated into culture media prepared as in Example 3 but substituting glycogen for starch. Each day the cultures were examined by microscope and it was observed that the cells grew at the same rate and to the same density as a culture containing glucose, but the medium did not become acidic.
What is claimed is:
1. In the method of culturing mammalian cells in a culture medium which supplies nutrients including glucose to said mammalian cells:
The improvement of maintaining the glucose concentration in said culture medium at a desired concentration by providing sustained release of glucose at a controlled rate by including in the culture medium a compound containing an enzymaticallyreleasable glucosyl moiety and an enzyme activity capable of releasing glucose from said glucosylcontaining compound, said glucosyl-containing compound being present in an amount sufficient to provide sustained release of glucose and said enzyme activity being present at a level sufficient to maintain the glucose at the desired concentration.
2. The improvement of claim 1 wherein said enzyme activity is supplied by the presence in said culture medium of at least one hydrolytic enzyme.
3. The improvement of claim 2 wherein said hydrolytic enzyme comprises a glucosidase.
4. The improvement of claim 3 wherein said glucosylcontaining compound comprises an oligosaccharide.
5. The improvement of claim 4 wherein said oligosaccharide comprises maltose and said glucosidase comprises maltase.
6. The improvement of claim 3 wherein said glucosylcontaining compound comprises a polysaccharide.
7. The improvement of claim 6 wherein said polysaccharide comprises starch and said glucosidase comprises amylase and maltase.
8. The improvement of claim 6 wherein said polysaccharide comprises glycogen and said glucosidase comprises amylase and maltase.
9. The improvement of claim 1 wherein said enzyme activity is supplied to said culture medium by adding serum thereto.
10. The improvement of claim 9 wherein said serum comprises fetal calf serum.
11. The improvement of claim 5 wherein maltase is supplied to said culture medium by adding serum thereto.
12. The improvement of claim 11 wherein said serum comprises fetal calf serum.
13. The improvement of claim 7 wherein amylase and maltase are supplied to said culture medium by adding fetal calf serum thereto.
14. The improvement of claim 1 wherein said enzyme activity is included in an amount sufiicient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
15. The improvement of claim 4 wherein said glucosidase is included in an amount sufficient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
16. The improvement of claim 6 wherein said glucosidase is included in an amount suflicient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
17. The improvement of claim 9 wherein sufficient serum is added to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter.
10 activity in the serum added to said culture medium is reduced by heating the serum to an elevated temperature prior to its addition to the culture medium.
19. The improvement of claim 18 wherein said enzyme activity is supplied by the presence in said serum of at least one hydrolytic enzyme.
20. The improvement of claim 19 wherein said hydrolytic enzyme comprises a glucosidase.
21. The improvement of claim 20 wherein said serum comprises fetal calf serum.
23. The improvement of claim 22 wherein the glucosidase activity in said serum is reduced by heating said serum.
Claims (23)
1. IN THE METHOD OF CULTURING MAMMALIAN CELLS IN A CULTURE MEDIUM WHICH SUPPLIES NUTRIENTS INCLUDING GLUCOSE TO SAID MAMMALIAN CELLS: THE IMPROVEMENT OF MAINTAINING THE FLUCOSE CONCENTRATION IN SAID CULTURE MEDIUM AT A DESIRED CONCENTRATION BY PROVIDING SUSTAINED RELEASE OF FLUCOSE AT A CONTROLLED RATE BY INCLUDING IN THE CULTURE MEDIUM A COMPOUND CONTAINING AN ENZYMATICALLY-RELEASABLE GLUCOSYL MOIETY AND AN ENZYME ACTIVITY CAPABLE OF RELEASING GLUCOSE FROM SAID FLUCOSYL-CONTAINING COMPOUND, SAID FLUCOSYL-CONTAINING COMPOUND BEING PRESENT IN AN AMOUNT SUFFICIENT TO PROVIDE SUSTAINED RELEASE OF FLUCOSE AND SAID ENZYME ACTIVITY BEING PRESENT AT A LEVEL SUFFICIENT TO MAINTAIN THE FLUCOSE AT THE DESIRED CONCENTRATION.
2. The improvement of claim 1 wherein said enzyme activity is supplied by the presence in said culture medium of at least one hydrolytic enzyme.
3. The improvement of claim 2 wherein said hydrolytic enzyme comprises a glucosidase.
4. The improvement of claim 3 wherein said glucosyl-containing compound comprises an oligosaccharide.
5. The improvement of claim 4 wherein said oligosaccharide comprises maltose and said glucosidase comprises maltase.
6. The improvement of claim 3 wherein said glucosyl-containing compound comprises a polysaccharide.
7. The improvement of claim 6 wherein said polysaccharide comprises starch and said glucosidase comprises amylase and maltase.
8. The improvement of claim 6 wherein said polysaccharide comprises glycogen and said glucosidase comprises amylase and maltase.
9. The improvement of claim 1 wherein said enzyme activity is supplied to said culture medium by adding serum thereto.
10. The improvement of claim 9 wherein said serum comprises fetal calf serum.
11. The improvement of claim 5 wherein maltase is supplied to said culture medium by adding serum thereto.
12. The improvement of claim 11 wherein said serum comprises fetal calf serum.
13. The improvement of claim 7 wherein amylase and maltase are supplied to said culture medium by adding fetal calf serum thereto.
14. The improvement of claim 1 wherein said enzyme activity is included in an amount sufficient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
15. The improvement of claim 4 wherein said glucosidase is included in an amount sufficient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
16. The improvement of claim 6 wherein said glucosidase is included in an amount sufficient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
17. The improvement of claim 9 wherein sufficient serum is added to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter.
18. The improvement of claim 9 wherein the enzyme activity in the serum added to said culture medium is reduced by heating the serum to an elevated temperature prior to its addition to the culture medium.
19. The improvement of claim 18 wherein said enzyme activity is supplied by the presence in said serum of at least one hydrolytic enzyme.
20. The improvement of claim 19 wherein said hydrolytic enzyme comprises a glucosidase.
21. The improvement of claim 20 wherein said serum comprises fetal calf serum.
22. In the method of growing mammalian cell cultures wherein serum containing glucasidase activity is added to a mammalian cell culture medium to release glucose from glucosyl-containing compound to maintain a desired glucose concentration: the improvement of regulating the glucose concentration in said culture medium by regulating the glucosidase activity of the serum prior to its addition to the culture medium.
23. The improvement of claim 22 wherein the glucosidase activity in said serum is reduced by heating said serum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US495609A US3926723A (en) | 1974-08-08 | 1974-08-08 | Method of controllably releasing glucose to a cell culture medium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US495609A US3926723A (en) | 1974-08-08 | 1974-08-08 | Method of controllably releasing glucose to a cell culture medium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3926723A true US3926723A (en) | 1975-12-16 |
Family
ID=23969285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US495609A Expired - Lifetime US3926723A (en) | 1974-08-08 | 1974-08-08 | Method of controllably releasing glucose to a cell culture medium |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3926723A (en) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4230806A (en) * | 1977-06-07 | 1980-10-28 | Mitsui Engineering & Shipbuilding Co., Ltd. | Process for the production of microbial protein and lipid from vegetable carbohydrates by culture of microbes |
| WO1987000195A1 (en) * | 1985-06-28 | 1987-01-15 | Celltech Limited | Animal cell culture |
| US4937194A (en) * | 1986-05-12 | 1990-06-26 | Baxter International Inc. | Method for metering nutrient media to cell culture containers |
| US5672502A (en) * | 1985-06-28 | 1997-09-30 | Celltech Therapeutics Limited | Animal cell culture |
| US5856179A (en) * | 1994-03-10 | 1999-01-05 | Genentech, Inc. | Polypeptide production in animal cell culture |
| US6020148A (en) * | 1992-02-04 | 2000-02-01 | The Procter & Gamble Company | In vitro method for eye and skin irritation testing |
| US20030087372A1 (en) * | 2001-06-13 | 2003-05-08 | Genentech, Inc. | Methods of culturing animal cells and polypeptide production in animal cells |
| EP1609853A1 (en) | 1995-06-06 | 2005-12-28 | F.Hoffmann-La Roche Ag | Process for controlling sialylation of proteins produced by mammalian cell culture |
| WO2008065254A1 (en) | 2006-11-30 | 2008-06-05 | Oulun Yliopisto | Method for controlling the growth of cell culture |
| EP2130906A1 (en) | 2008-06-04 | 2009-12-09 | BioSilta Oy | Method for the supply of growth components to cell cultures |
| EP2226380A1 (en) | 2009-03-05 | 2010-09-08 | BioSilta Oy | Enzyme-based fed-batch technique in liquid cultures |
| DE102010013852A1 (en) | 2010-04-01 | 2011-10-06 | M2P-Labs Gmbh | Process for the process control of a reactant-limited, biochemical reaction |
| WO2016085787A1 (en) | 2014-11-25 | 2016-06-02 | Corning Incorporated | Cell culture media extending materials and methods |
| US10501769B2 (en) | 2009-10-26 | 2019-12-10 | Hoffmann-La Roche Inc. | Method for the production of a glycosylated immunoglobulin |
| CN120843415A (en) * | 2025-09-22 | 2025-10-28 | 华中科技大学同济医学院附属同济医院 | A glucose sustained-release structure for embryo in vitro culture medium, preparation process and use method |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2658021A (en) * | 1949-11-30 | 1953-11-03 | Earle Wilton Robinson | Single tissue cell culturing procedure |
| US2891869A (en) * | 1953-06-03 | 1959-06-23 | Staley Mfg Co A E | Process for preparing starch syrups |
| US3128228A (en) * | 1960-03-04 | 1964-04-07 | Ustav Ser A Ockovacich Latek | Tissue culture medium |
| US3242055A (en) * | 1962-07-10 | 1966-03-22 | Lucia Santo De | Process and composition for enhancing bacterial action on septic tanks and the like, and method of making said composition |
| US3850748A (en) * | 1973-06-28 | 1974-11-26 | Lilly Co Eli | Method of producing animal cells in suspension culture |
-
1974
- 1974-08-08 US US495609A patent/US3926723A/en not_active Expired - Lifetime
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2658021A (en) * | 1949-11-30 | 1953-11-03 | Earle Wilton Robinson | Single tissue cell culturing procedure |
| US2891869A (en) * | 1953-06-03 | 1959-06-23 | Staley Mfg Co A E | Process for preparing starch syrups |
| US3128228A (en) * | 1960-03-04 | 1964-04-07 | Ustav Ser A Ockovacich Latek | Tissue culture medium |
| US3242055A (en) * | 1962-07-10 | 1966-03-22 | Lucia Santo De | Process and composition for enhancing bacterial action on septic tanks and the like, and method of making said composition |
| US3850748A (en) * | 1973-06-28 | 1974-11-26 | Lilly Co Eli | Method of producing animal cells in suspension culture |
Cited By (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4230806A (en) * | 1977-06-07 | 1980-10-28 | Mitsui Engineering & Shipbuilding Co., Ltd. | Process for the production of microbial protein and lipid from vegetable carbohydrates by culture of microbes |
| WO1987000195A1 (en) * | 1985-06-28 | 1987-01-15 | Celltech Limited | Animal cell culture |
| GB2195655A (en) * | 1985-06-28 | 1988-04-13 | Celltech Ltd | Animal cell culture |
| GB2195655B (en) * | 1985-06-28 | 1989-10-25 | Celltech Ltd | Animal cell culture |
| US5672502A (en) * | 1985-06-28 | 1997-09-30 | Celltech Therapeutics Limited | Animal cell culture |
| US4937194A (en) * | 1986-05-12 | 1990-06-26 | Baxter International Inc. | Method for metering nutrient media to cell culture containers |
| US6020148A (en) * | 1992-02-04 | 2000-02-01 | The Procter & Gamble Company | In vitro method for eye and skin irritation testing |
| US5856179A (en) * | 1994-03-10 | 1999-01-05 | Genentech, Inc. | Polypeptide production in animal cell culture |
| US6180401B1 (en) | 1994-03-10 | 2001-01-30 | Genentech, Inc. | Polypeptide production in animal cell culture |
| US20040048368A1 (en) * | 1994-03-10 | 2004-03-11 | Genentech, Inc. | Polypeptide production in animal cell culture |
| US20050272124A1 (en) * | 1994-03-10 | 2005-12-08 | Genentech, Inc. | Polypeptide production in animal cell culture |
| EP1609853A1 (en) | 1995-06-06 | 2005-12-28 | F.Hoffmann-La Roche Ag | Process for controlling sialylation of proteins produced by mammalian cell culture |
| US20030087372A1 (en) * | 2001-06-13 | 2003-05-08 | Genentech, Inc. | Methods of culturing animal cells and polypeptide production in animal cells |
| US20100099164A1 (en) * | 2006-11-30 | 2010-04-22 | Oulun Yliopisto | Method for controlling the growth of cell culture |
| WO2008065254A1 (en) | 2006-11-30 | 2008-06-05 | Oulun Yliopisto | Method for controlling the growth of cell culture |
| US9228167B2 (en) | 2006-11-30 | 2016-01-05 | Oulun Yliopisto | Method for controlling the growth of cell culture |
| US20110244573A1 (en) * | 2008-06-04 | 2011-10-06 | Biosilta Oy | Method For The Supply Of Growth Components To Cell Cultures |
| WO2009147200A3 (en) * | 2008-06-04 | 2010-01-28 | Biosilta Oy | Method for the supply of growth components to cell cultures |
| EP2130906A1 (en) | 2008-06-04 | 2009-12-09 | BioSilta Oy | Method for the supply of growth components to cell cultures |
| WO2010100239A1 (en) | 2009-03-05 | 2010-09-10 | Biosilta Oy | Enzyme-based fed-batch technique in liquid cultures |
| US9127261B2 (en) | 2009-03-05 | 2015-09-08 | Biosilta Oy | Enzyme-based fed-batch technique in liquid cultures |
| EP2226380A1 (en) | 2009-03-05 | 2010-09-08 | BioSilta Oy | Enzyme-based fed-batch technique in liquid cultures |
| AU2010220253B2 (en) * | 2009-03-05 | 2016-02-25 | Biosilta Oy | Enzyme-based fed-batch technique in liquid cultures |
| US10501769B2 (en) | 2009-10-26 | 2019-12-10 | Hoffmann-La Roche Inc. | Method for the production of a glycosylated immunoglobulin |
| US11021728B2 (en) | 2009-10-26 | 2021-06-01 | Hoffmann-La Roche Inc. | Method for the production of a glycosylated immunoglobulin |
| US11136610B2 (en) | 2009-10-26 | 2021-10-05 | Hoffmann-La Roche Inc. | Method for the production of a glycosylated immunoglobulin |
| US11377678B2 (en) | 2009-10-26 | 2022-07-05 | Hoffman-La Roche Inc. | Method for the production of a glycosylated immunoglobulin |
| DE102010013852A1 (en) | 2010-04-01 | 2011-10-06 | M2P-Labs Gmbh | Process for the process control of a reactant-limited, biochemical reaction |
| WO2016085787A1 (en) | 2014-11-25 | 2016-06-02 | Corning Incorporated | Cell culture media extending materials and methods |
| EP3865563A1 (en) | 2014-11-25 | 2021-08-18 | Corning Incorporated | Cell culture media extending materials and methods |
| US11932838B2 (en) | 2014-11-25 | 2024-03-19 | Corning Incorporated | Cell culture media extending materials and methods |
| CN120843415A (en) * | 2025-09-22 | 2025-10-28 | 华中科技大学同济医学院附属同济医院 | A glucose sustained-release structure for embryo in vitro culture medium, preparation process and use method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rheinwald et al. | Growth of cultured mammalian cells on secondary glucose sources | |
| Jeffrey et al. | The role of ascorbic acid in the biosynthesis of collagen I. Ascorbic acid requirement by embryonic chick tibia in tissue culture | |
| Ambrus et al. | Phenylalanine depletion for the management of phenylketonuria: use of enzyme reactors with immobilized enzymes | |
| Vonderhaar et al. | An early effect of prolactin on the formation of α-lactalbumin by mouse mammary epithelial cells | |
| Ishihara et al. | Correlations between heparan sulfate metabolism and hepatoma growth | |
| Briggs | Origin and distribution of α‐amylase in malt | |
| Harold et al. | A genetic defect in retention of potassium by Streptococcus faecalis | |
| Nagasawa et al. | Factors influencing the induction of sister chromatid exchanges in mammalian cells by 12-O-tetradecanoyl-phorbol-13-acetate | |
| Löffler | On the role of dihydroorotate dehydrogenase in growth cessation of Ehrlich ascites tumor cells cultured under oxygen deficiency | |
| Steck et al. | Glycolysis in chick embryo cell cultures transformed by Rous sarcoma virus | |
| Breen et al. | Respiration-deficient Chinese hamster cell mutants: biochemical characterization | |
| Reuser et al. | Adult forms of glycogenosis type II: A defect in an early stage of acid α-glucosidase realization | |
| Terracciano et al. | Enhancement of chemotaxis in Spirochaeta aurantia grown under conditions of nutrient limitation | |
| GOYAL et al. | Regulation of dextransucrase productivity of Leuconostoc mesenteroides NRRL B-512F by the maintenance media | |
| Storrie et al. | The role of butyrate in the reverse transformation reaction in mammalian cells | |
| Bansal et al. | Evidence for rapid metabolic turnover of hyaluronate synthetase in Swarm rat chondrosarcoma chondrocytes | |
| Wilcox | Extracellular release of acid hydrolases from cultured retinal pigmented epithelium. | |
| Rein et al. | On the survival of chick embryo cells at low concentrations in culture | |
| Sens et al. | Effects of pyruvate on the growth of normal and transformed hamster embryo fibroblasts | |
| Nakamura et al. | Hormonal control of the development of tryptophan oxygenase in primary cultures of young rat hepatocytes | |
| Armelin et al. | Steroid hormones mediate reversible phenotypic transition between transformed and untransformed states in mouse fibroblasts. | |
| Amos et al. | Regulation of glucose transport in chick fibroblasts: bicarbonate, lactate and ascorbic acid | |
| Gerschenson et al. | Regulation of the pyruvate kinase of an established rat liver cell line (RLC) in culture by insulin, glucose and serum | |
| Steele | Human serum as a culture medium for rat embryos | |
| PITOT et al. | Control of Biochemical Expression in Morpho-logically Related Cells In Vivo and In Vitro 1, 2 |